Clin2
NCT07553442Possibly a fitRecruiting

Testing ALN-AGT01 RVR for mild to moderate high blood pressure

Hypertension

Part of Heart & circulation clinical trials.

This study tests a new experimental drug called ALN-AGT01 RVR in people with mild to moderate high blood pressure. The drug may help lower blood pressure by targeting a protein in the body that regulates blood pressure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
93 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • Be an adult (18 or older) with high blood pressure readings between 130–170 mmHg
  • Not take blood pressure medications, or take up to 2 stable medications (Part A only)
  • Have stopped most blood pressure medications for at least 3 weeks, except calcium channel blockers or water pills (Part B only)
  • Not have secondary hypertension (high blood pressure caused by another medical condition)
  • Have normal kidney function and balanced potassium levels

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07833098Not yet recruiting· Phase 2
A new medicine for hard-to-control high blood pressure

This study tests a new investigational medicine called VB19055 for people whose high blood pressure is not controlled even though they are already taking multiple blood pressure medications. The trial aims to see if this new drug can help lower blood pressure more effectively.

Baotou
NCT07758634Recruiting· Phase 1/Phase 2
Study of an experimental treatment for high blood pressure

This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.

Port Orange, Florida
NCT07876544Recruiting· Phase 4
New drug plus amlodipine for high blood pressure and early kidney damage

This trial tests a new medicine (sitogilun malate) combined with a standard blood pressure drug (amlodipine) to see if it protects the kidneys in people with early kidney damage caused by high blood pressure. Participation could help prevent further kidney damage while controlling your blood pressure.

Shanghai, China
NCT05688579Enrolling by invitation· Phase 4
Testing an aldosterone-blocking medicine in hard-to-control hypertension

This trial studies whether a medicine that blocks aldosterone (called an MRA) can improve cardiovascular outcomes in people with high aldosterone levels and high blood pressure. You may be asked to take the study medicine and have blood pressure, heart, and lab tests monitored over time.

Ürümqi, Xinjiang
NCT04971720Recruiting· Phase 2/Phase 3
Personalized blood pressure timing therapy for some adults

This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.

Birmingham, Alabama
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.